Attachment D: Selection and Assignment of Oasis Diagnosis
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Surgical Options for Breast Cancer
The Breast Center Smilow Cancer Hospital 20 York Street, North Pavilion New Haven, CT 06510 Phone: (203) 200-2328 Fax: (203) 200-2075 SURGICAL OPTIONS There are a number of surgical procedures available today for the treatment of breast cancer. You will likely have a choice and will need to make your own decision, in consultation with your specific surgeon, about the best option for you. We offer you a choice because the research on the treatment of breast cancer has clearly shown that the cure and survival rates are the same regardless of what you choose. The choices can be divided into breast conserving options (i.e. lumpectomy or partial mastectomy) or breast removing options (mastectomy). A procedure to evaluate your armpit (axillary) lymph nodes will likely occur at the same time as your breast surgery. This is done to help determine the likelihood that cells from your breast cancer have left the breast and spread (metastasized) to another more dangerous location. This information will be used to help decide about your need for chemotherapy or hormone blocking drugs after surgery. PARTIAL MASTECTOMY (LUMPECTOMY) A partial mastectomy involves removing the cancer from your breast with a rim, or margin, of normal breast tissue. This allows the healthy noncancerous part of your breast to be preserved, and usually will not alter the sensation of the nipple. The benefit of this surgical choice is that it often preserves the cosmetics of the breast. Your surgeon will make a decision about the volume of tissue that needs removal in order to maximize the chance of clear margins as confirmed by our pathologist. -
Disease Discovery Classification of Lymphoid Neoplasms
From www.bloodjournal.org by on December 4, 2008. For personal use only. 2008 112: 4384-4399 doi:10.1182/blood-2008-07-077982 Classification of lymphoid neoplasms: the microscope as a tool for disease discovery Elaine S. Jaffe, Nancy Lee Harris, Harald Stein and Peter G. Isaacson Updated information and services can be found at: http://bloodjournal.hematologylibrary.org/cgi/content/full/112/12/4384 Articles on similar topics may be found in the following Blood collections: Neoplasia (4200 articles) Free Research Articles (544 articles) ASH 50th Anniversary Reviews (32 articles) Clinical Trials and Observations (2473 articles) Information about reproducing this article in parts or in its entirety may be found online at: http://bloodjournal.hematologylibrary.org/misc/rights.dtl#repub_requests Information about ordering reprints may be found online at: http://bloodjournal.hematologylibrary.org/misc/rights.dtl#reprints Information about subscriptions and ASH membership may be found online at: http://bloodjournal.hematologylibrary.org/subscriptions/index.dtl Blood (print ISSN 0006-4971, online ISSN 1528-0020), is published semimonthly by the American Society of Hematology, 1900 M St, NW, Suite 200, Washington DC 20036. Copyright 2007 by The American Society of Hematology; all rights reserved. From www.bloodjournal.org by on December 4, 2008. For personal use only. ASH 50th anniversary review Classification of lymphoid neoplasms: the microscope as a tool for disease discovery Elaine S. Jaffe,1 Nancy Lee Harris,2 Harald Stein,3 and Peter -
Lumpectomy/Mastectomy Patient/Family Education
LUMPECTOMY/MASTECTOMY PATIENT/FAMILY EDUCATION Being diagnosed with breast cancer can be emotionally challenging. It is important to learn as much as possible about your cancer and the available treatments. More than one type of treatment is commonly recommended for breast cancer. Each woman’s situation is unique and which treatment or treatments that will be recommended is based on tumor characteristics, stage of disease and patient preference. Surgery to remove the cancer is an effective way to control breast cancer. The purpose of this educational material is to: increase the patient’s and loved ones’ knowledge about lumpectomy and mastectomy to treat breast cancer; reduce anxiety about the surgery; prevent post-operative complications; and to facilitate physical and emotional adjustment after breast surgery. THE BASICS There are three primary goals of breast cancer surgery: 1. To remove a cancerous tumor or other abnormal area from the breast and enough surrounding breast tissue to leave a “margin of safety” around the tumor or affected area. 2. To remove lymph nodes from the armpit area (axilla) to check for possible spread of cancer (metastasis) or remove lymph nodes that are already known to contain cancer. 3. Sometimes one or both breasts are removed to prevent breast cancer if a woman is at especially high risk for the disease. Breast cancer surgery can be done before or after chemotherapy (if chemotherapy is recommended). Radiation therapy and hormonal therapy (if recommended) are typically done after surgery. There are several types of breast surgery. The type of surgery best suited for a specific woman depends on the type of breast disease, the size and location of the breast disease/tumor(s) in the breast, and the personal preference of the patient. -
Advances in Breast Reconstruction After Lumpectomy and Mastectomy
ADVANCES IN BREAST RECONSTRUCTION AFTER LUMPECTOMY AND MASTECTOMY Breast cancer has been described as far back as 1600 B.C. in the papyrus writings of the ancient Egyptians. Galen later theorized that the cancer was due to a collection “of black bile” inside the breast. Virchow proposed this so-called “tumor” originated from the epithelium and spread outward in all directions. The American surgeon William Halsted supported the theory that breast cancer began as a “regional” phenomenon, before it spread distantly. And in 1882 he first performed the first Radical Mastectomy, which involved removal of the entire breast, the lymph nodes in the area, and the underlying pectoralis chest wall muscles. As you can imagine, this led to a very disfiguring appearance, but Halsted was able to achieve a 5-year cure rate of 40% which was unheard of at the time. Because of Halsted’s principles, breast reconstruction was really never an option since it was considered a “violation of the local control of the disease.” Halsted warned surgeons not to perform plastic operations at the mastectomy site because he believed it could hide local recurrence and “may sacrifice his patient to disease.” Therefore, many of the initial attempts at breast reconstruction took place in Europe. EARLY BREAST RECONSTRUCTION Breast reconstruction itself dates back to the 1800s, with the initial attempt taking place in 1895 by the German surgeon, Vincent Czerny. He reported the case of a 41 year old singer who required a mastectomy for a fibroadenoma and chronic infections. He reported that “since both breasts were very well developed” she would have “an unpleasant asymmetry” after removal of one breast, which would have “hindered her stage activity”. -
Consensus Guideline on the Management of the Axilla in Patients with Invasive/In-Situ Breast Cancer
- Official Statement - Consensus Guideline on the Management of the Axilla in Patients With Invasive/In-Situ Breast Cancer Purpose To outline the management of the axilla for patients with invasive and in-situ breast cancer. Associated ASBrS Guidelines or Quality Measures 1. Performance and Practice Guidelines for Sentinel Lymph Node Biopsy in Breast Cancer Patients – Revised November 25, 2014 2. Performance and Practice Guidelines for Axillary Lymph Node Dissection in Breast Cancer Patients – Approved November 25, 2014 3. Quality Measure: Sentinel Lymph Node Biopsy for Invasive Breast Cancer – Approved November 4, 2010 4. Prior Position Statement: Management of the Axilla in Patients With Invasive Breast Cancer – Approved August 31, 2011 Methods A literature review inclusive of recent randomized controlled trials evaluating the use of sentinel lymph node surgery and axillary lymph node dissection for invasive and in-situ breast cancer as well as the pathologic review of sentinel lymph nodes and indications for axillary radiation was performed. This is not a complete systematic review but rather, a comprehensive review of recent relevant literature. A focused review of non-randomized controlled trials was then performed to develop consensus guidance on management of the axilla in scenarios where randomized controlled trials data is lacking. The ASBrS Research Committee developed a consensus document, which was reviewed and approved by the ASBrS Board of Directors. Summary of Data Reviewed Recommendations Based on Randomized Controlled -
LIST of OCCUPATIONAL DISEASES (Revised 2010)
LIST OF OCCUPATIONAL DISEASES (revised 2010) Identification and recognition of occupational diseases: Criteria for incorporating diseases in the ILO list of occupational diseases Occupational Safety and Health Series, No. 74 List of occupational diseases (revised 2010) Identification and recognition of occupational diseases: Criteria for incorporating diseases in the ILO list of occupational diseases INTERNATIONAL LABOUR OFFICE • GENEVA Copyright © International Labour Organization 2010 First published 2010 Publications of the International Labour Office enjoy copyright under Protocol 2 of the Universal Copyright Convention. Nevertheless, short excerpts from them may be reproduced without authorization, on condition that the source is indicated. For rights of reproduction or translation, application should be made to ILO Publications (Rights and Permissions), International Labour Office, CH-1211 Geneva 22, Switzerland, or by email: pubdroit@ ilo.org. The International Labour Office welcomes such applications. Libraries, institutions and other users registered with reproduction rights organizations may make copies in accordance with the licences issued to them for this purpose. Visit www.ifrro.org to find the reproduction rights organization in your country. ILO List of occupational diseases (revised 2010). Identification and recognition of occupational diseases: Criteria for incorporating diseases in the ILO list of occupational diseases Geneva, International Labour Office, 2010 (Occupational Safety and Health Series, No. 74) occupational disease / definition. 13.04.3 ISBN 978-92-2-123795-2 ISSN 0078-3129 Also available in French: Liste des maladies professionnelles (révisée en 2010): Identification et reconnaissance des maladies professionnelles: critères pour incorporer des maladies dans la liste des maladies professionnelles de l’OIT (ISBN 978-92-2-223795-1, ISSN 0250-412x), Geneva, 2010, and in Spanish: Lista de enfermedades profesionales (revisada en 2010). -
ICD-10 International Statistical Classification of Diseases and Related Health Problems
ICD-10 International Statistical Classification of Diseases and Related Health Problems 10th Revision Volume 2 Instruction manual 2010 Edition WHO Library Cataloguing-in-Publication Data International statistical classification of diseases and related health problems. - 10th revision, edition 2010. 3 v. Contents: v. 1. Tabular list – v. 2. Instruction manual – v. 3. Alphabetical index. 1.Diseases - classification. 2.Classification. 3.Manuals. I.World Health Organization. II.ICD-10. ISBN 978 92 4 154834 2 (NLM classification: WB 15) © World Health Organization 2011 All rights reserved. Publications of the World Health Organization are available on the WHO web site (www.who.int) or can be purchased from WHO Press, World Health Organization, 20 Avenue Appia, 1211 Geneva 27, Switzerland (tel.: +41 22 791 3264; fax: +41 22 791 4857; e-mail: [email protected]). Requests for permission to reproduce or translate WHO publications – whether for sale or for noncommercial distribution – should be addressed to WHO Press through the WHO web site (http://www.who.int/about/licensing/copyright_form). The designations employed and the presentation of the material in this publication do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent approximate border lines for which there may not yet be full agreement. The mention of specific companies or of certain manufacturers’ products does not imply that they are endorsed or recommended by the World Health Organization in preference to others of a similar nature that are not mentioned. -
FAQ REGARDING DISEASE REPORTING in MONTANA | Rev
Disease Reporting in Montana: Frequently Asked Questions Title 50 Section 1-202 of the Montana Code Annotated (MCA) outlines the general powers and duties of the Montana Department of Public Health & Human Services (DPHHS). The three primary duties that serve as the foundation for disease reporting in Montana state that DPHHS shall: • Study conditions affecting the citizens of the state by making use of birth, death, and sickness records; • Make investigations, disseminate information, and make recommendations for control of diseases and improvement of public health to persons, groups, or the public; and • Adopt and enforce rules regarding the reporting and control of communicable diseases. In order to meet these obligations, DPHHS works closely with local health jurisdictions to collect and analyze disease reports. Although anyone may report a case of communicable disease, such reports are submitted primarily by health care providers and laboratories. The Administrative Rules of Montana (ARM), Title 37, Chapter 114, Communicable Disease Control, outline the rules for communicable disease control, including disease reporting. Communicable disease surveillance is defined as the ongoing collection, analysis, interpretation, and dissemination of disease data. Accurate and timely disease reporting is the foundation of an effective surveillance program, which is key to applying effective public health interventions to mitigate the impact of disease. What diseases are reportable? A list of reportable diseases is maintained in ARM 37.114.203. The list continues to evolve and is consistent with the Council of State and Territorial Epidemiologists (CSTE) list of Nationally Notifiable Diseases maintained by the Centers for Disease Control and Prevention (CDC). In addition to the named conditions on the list, any occurrence of a case/cases of communicable disease in the 20th edition of the Control of Communicable Diseases Manual with a frequency in excess of normal expectancy or any unusual incident of unexplained illness or death in a human or animal should be reported. -
Mastectomy for Invasive Breast Cancer 1 4
Mastectomy for Invasive Breast Cancer 1 4 Tracy-Ann Moo and Rache M. Simmons Abbreviations transection of the long thoracic and thoracodor- sal nerves, which was routinely performed at DCIS Ductal carcinoma in situ the time. NAC Nipple-areola complex By the mid-1900s, the modifi ed radical mastectomy, which spared the pectoral muscles, began to gain widespread support as a less Introduction morbid procedure that could achieve results equivalent to the radical mastectomy [ 3 – 6 ]. The The mastectomy procedure has evolved consider- modifi ed radical mastectomy would in subse- ably since the era of the radical mastectomy. In quent decades be replaced by the total or simple the late 1800s, Halsted and Mayer described the mastectomy, which eliminated the axillary radical mastectomy in individual reports on the lymph node dissection. However, around the treatment of breast cancer. The radical mastec- same time, other groups advocated for a more tomy involved removal of the breast and pectoral extensive resection as a means of achieving muscles in conjunction with an axillary and greater local control, the extended radical mas- infraclavicular lymph node dissection [1 , 2 ]. At a tectomy [ 7 , 8 ]. The extended radical mastec- time when no effective adjuvant treatment tomy was a more morbid procedure removing existed, this en bloc resection provided the best not only the infraclavicular and axillary lymph rates of local control. The obvious drawbacks to nodes but also the supraclavicular and paraster- such a radical procedure included chronic lymph- nal lymph nodes. edema, as well as neurologic defi cits related to To address this growing dichotomy in surgical treatment options, the fi rst randomized trials in breast cancer treatment were conceived. -
Breast Cancer Surgery and Oncoplastic Techniques Aaron D
Breast CanCer surgery and OnCOplastiC teChniques Aaron D. Bleznak, MD, MBA, FACS Medical Director Breast Program, Ann B. Barshinger Cancer Institute Penn Medicine Lancaster General Health INTRODUCTION For more than a century after the standardiza- compared total mastectomy to lumpectomy (breast tion of the radical mastectomy procedure by William conserving surgery or BCS) with or without radiation Stewart Halsted at Johns Hopkins in the late 19th therapy, demonstrated that the extent of surgery does century, the mainstay of breast cancer treatment not impact cure rates1,2 (Fig. 1). Other randomized has been surgical resection. Removal of the primary trials in the United States and internationally, with breast cancer is curative for those women whose as much as 35 years of follow-up, have confirmed that malignancy has not metastasized to distant sites, and the extent of resection does not affect disease-specific in the current era of mammographic screening, that and overall survival rates.3 is the fortunate status of most women when their Over the ensuing decade after the landmark breast cancer is first diagnosed. NSABP B-06 study, these lessons were incorporated Our understanding of the route of breast can- into oncologic practice, and we achieved a relatively cer metastasis has evolved since Halsted’s time. His steady state in rates of breast conservation (Fig. 2, theory of initial spread via lymphatic channels, which next page). From 2007 to 2016, breast-conserving eventually empty into the vascular system, has evolved surgery was used in approximately 60% of women into our current appreciation that primary spread is with breast cancer cared for in hospitals accredited hematogenous. -
Frequently Asked Questions About Coding for Breast Surgery
CODING AND PRACTICE MANAGEMENT CORNER Frequently asked questions about coding for breast surgery 52 | by Linda Barney, MD, FACS; Mark Savarise, MD, FACS; and Eric Whitacre, MD, FACS All of the image-guided oding for surgical services biopsy codes, 19081–19086, can be complicated due Why are there two separate specify that the biopsy is Cto the numerous rules, codes to report for breast inclusive of the placement guidelines, and exceptions— cancer operations with of breast localization all of which the Centers sentinel node biopsy and one unified code for mastectomy devices, including clips for Medicare & Medicaid Services frequently updates or lumpectomy with and metallic pellet when and revises. Consequently, the axillary node dissection? performed, and imaging American College of Surgeons The breast surgery Current of the biopsy specimen, (ACS) General Surgery Procedural Terminology (CPT) when performed. Coding and Reimbursement codes were developed when Committee (GSCRC) often axillary dissection was standard receives questions about therapy for breast cancer. coding, particularly for Modified radical mastectomy breast surgery. This column is coded 19307; lumpectomy responds to some frequently with axillary dissection is coded asked coding questions 19302. When sentinel lymph related to breast cancer node biopsy was developed, the operations, sentinel node code needed to be applied to both biopsy, ultrasound-guided core breast and melanoma procedures. biopsies, excision with wires, Code 38900 is an add-on code to intraoperative assessment be used with any lymph node of margins, and more. biopsy or lymphadenectomy code V99 No 9 BULLETIN American College of Surgeons CODING AND PRACTICE MANAGEMENT CORNER to indicate the intraoperative placement of breast localization describes the procedure where work done to identify the devices, including clips and margin status is indicated by any sentinel lymph nodes. -
Radical Mastectomy to Radical Conservation (Extreme Oncoplasty): a Revolutionary Change
IS RAVDIN LECTURE IN THE BASIC AND SURGICAL SCIENCES Radical Mastectomy to Radical Conservation (Extreme Oncoplasty): A Revolutionary Change Melvin J Silverstein, MD, FACS After 4 decades of caring for patients with breast cancer, I seen a case in which it was used, and probably have never have come to the conclusion that the combination of mas- even heard the term. tectomy, reconstruction, and radiation therapy is the least This article will take you on a 50-year journey, from desirable option for local treatment. Although it may be 1965 to the present: from radical mastectomy to extreme an unavoidable approach for some patients, for many oncoplasty, from mutilation to the opposite, to less local there may be better options that yield equal survival rates recurrence, to a lower breast cancer mortality rate, to with a superior quality of life. Let me explain. a better quality of life, to better cosmesis, and to breast Everyone knows the definition of radical mastectomy, a conservation even when mastectomy is thought to be procedure conceived and popularized by William S indicated. Halsted, MD. It removes the entire breast, the underlying pectoral muscles, and the axillary lymph nodes, leaving behind a depression under the clavicle, prominent ribs, LEARNING THE BASICS and a markedly deformed patient. Most younger surgeons I was a surgical resident from 1965 to 1970 at what was have never performed or even observed the procedure and then the Boston City Hospital, a group of more than never will. It has virtually no role in modern breast cancer 20 aging medical buildings connected by tunnels so that surgery.